{"id":5255,"date":"2025-10-27T11:15:21","date_gmt":"2025-10-27T09:15:21","guid":{"rendered":"https:\/\/cvja.co.za\/journal\/?p=5255"},"modified":"2026-05-05T16:02:55","modified_gmt":"2026-05-05T14:02:55","slug":"cvja-2025-080","status":"publish","type":"post","link":"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/","title":{"rendered":"Clinical and echocardiographic characteristics of patients who developed adverse events following Benzathine penicillin G injection for secondary prophylaxis of rheumatic heart disease: a cross-sectional study from three university hospitals in Ethiopia"},"content":{"rendered":"    <div id=\"article\">                                                                                                                        \r\n        <div id=\"title-container\">                                                                                                    \r\n        <div id=\"authors-title\">                                                                                                            \r\n        <!--Aurthors under Title-->                                                                                                            \r\n            \r\nAbraha Hailu Weldegerima, Dejuma Yadeta, Marta Yemane, Gabriele Wehr, Christian Leuner, Samuel Berhane, Abadi Leul, Tadesse Dukessa, Abraham Haileamlak\r\n        <\/div>        \r\n<\/div>                                                                                                                            \r\n            <div id=\"copyright\">\r\n        <strong>Copyright:<\/strong> Clinics Cardive Publishing (Pty) Ltd. publisher\r\n        of Cardiovascular Journal of Africa.<\/div>\r\n    <div style=\"clear: both;\"><\/div>                                                                                                                                \r\n        <div id=\"article-abstract\">                                                                                                            \r\n            <div id=\"abstract-title\">                                                                                                        \r\n                    Abstract                                                                                                                \r\n                <\/div>                                                                                                                        \r\n                                                                                                                                \r\n            <div id=\"abstract-content\">                                                                                                        \r\n            <!--Content of Abstract Article-->                                                                                                \r\n            <!--<strong>\"Abstract titles\":<\/strong>-->                                                                                        \r\n            <!--<br\/> at the end of each section!!-->                                                                                        \r\n                                                                                                                                            \r\n        <strong>Background:<\/strong>                                                                                                    \r\n                                                                                                                                                    \r\nIntramuscular (IM) Benzathine penicillin G administration (BPG) is essential to prevent the progression of acute rheumatic fever (RF) to rheumatic heart disease (RHD). Fatal adverse events during BPG administration have been reported. This study aimed to characterise the clinical features and outcomes of RHD patients who developed adverse events with BPG administration for RHD prophylaxis in Ethiopia.\r\n<br \/>                                                                                                                            \r\n                                                                                                                                                \r\n        <strong>Methods:<\/strong>                                                                                                    \r\n                                                                                                                                                    \r\nCharts of Patients who received BPG for secondary prophylaxis of RHD and had fatal adverse events were reviewed. An online survey was also used to collect data on adverse events during BPG injection. The study was done in Ethiopia at Ayder, Tikur Anbessa, and Jimma University Hospital from January 1, 2017, to May 30, 2023. Data were collected using a structured questionnaire. Demographic, clinical, and echocardiographic features were documented and analysed.\r\n<br \/>        \r\n                \r\n                <strong>Results:<\/strong>                                                                                                    \r\nAll five chart review cases were female. Four of them had fatal adverse events. Four of them were aged > 18 years. All had clinical evidence of heart failure (HF) and echocardiographically advanced RHD, including severe tricuspid regurgitation (TR) and moderate to severe pulmonary hypertension (PHTN). Case 1 was 24 years old with severe mitral stenosis (MS). Case 2 was 19 years old with severe mitral regurgitation (MR). Case 3 was 14 years old with moderate to severe aortic regurgitation (AR) and moderate to severe MR. Case 4 was 43 years old with severe MS and moderate MR. Case 5 was 16 years old with moderate-severe MS, severe MR and atrial fibrillation. Four had received BPG before the event with no previous adverse reaction. None of our cases met the Level 1 Brighton criteria consistent with anaphylaxis. There were four deaths, three skin rashes, and one anaphylactic shock reported from the six RHD cases from the online survey.\r\n<br \/>\r\n                                                                                                                                                                                                                                                                        \r\n                                                                                                                                                \r\n        <strong>Conclusion:<\/strong>                                                                                                    \r\n                                                                                                                                                    \r\nWe hypothesise that the coexistence of severe valve lesions with concomitant advanced HF may be an essential risk factor in BPG injection-related deaths rather than the presence of severe valve lesions alone. Heart failure and a failure of the compensatory mechanisms in BPG injection-related adverse circulatory reactions in advanced RHD with HF could be one of the major causes of these deaths. According to the literature, we recommend that patients with advanced RHD receive special attention regarding secondary BPG prophylaxis. For the introduction of less painful BPGinjection, like the subcutaneous technique, further research is needed.\r\n<br \/>    \r\n                                                                                                        \r\n\r\n                                                                                                                                                \r\n            <\/div>                                                                                                                            \r\n        <\/div>                                                                                                                                    \r\n                                                                                                                                        \r\n                                                                                                                                                \r\n        <div id=\"keywords\">                                                                                                                    \r\n                                                                                                                                            \r\n            <strong>Keywords:<\/strong>                                                                                                        \r\n                                                                                                                                            \r\n            <strong>BPG, RHD, adverse events, heart failure, Ethiopia<\/strong>                                                                                                                                                                                                                    \r\n                                                                                                                                                \r\n        <\/div>                                                                                                                                    \r\n                                                                                                                                                \r\n    <div id=\"publish-info\">                                                                                                                    \r\n                                                                                                                                \r\n    <strong>Submitted:<\/strong> July 27, 2025; <!--Month day, year; -->    \r\n    <strong>Accepted:<\/strong> August 4, 2025; <!--Month day, year; -->                                                                            \r\n    <strong>Published:<\/strong> October 27, 2025<!--Month day, year; -->                                                                                                                            <br \/>                                                            \r\n        <em>Cardiovasc J Afr 2025; <b>36<\/b>: 568-578<!--pg no. till pg no. \"eg. 4-7\"--><\/em>\r\n        <br \/><strong>Volume 36, Issue 4<\/strong> <br \/>                                                                            \r\n        <\/div>                                                                                                                            \r\n                                                                                                                                        \r\n    <div id=\"DOI\">                                                                                                                    \r\n            DOI Citation Reference: dx.doi.org\/10.5830\/CVJA-2025-080<!--DOI number-->                                                                \r\n        <\/div>                                                                                                                            \r\n                \r\n                <div id=\"author-affiliation\">                                                                                                \r\n\r\n<strong>Uganda Heart Institute, First Floor, Block C, Mulago Hospital Complex, Kampala, Uganda\r\n<\/strong>    <br \/>                                                                            \r\nDoreen Nakagaayi<br \/>\r\nJafesi Pulle<br \/>\r\nJenifer Atala<br \/>\r\nLinda M. Oyella<br \/>\r\nMiriam Nakitto<br \/>\r\nJoselyn Rwebembera<br \/>\r\nEmmy Okello\r\n\r\n<br \/><br \/>\r\n\r\n<strong>Mekelle University, College of Health Sciences, Department of Internal Medicine, Mekelle, Ethiopia\r\n<\/strong>    <br \/>                                                                            \r\nAbraha Hailu Weldegerima<br \/>\r\nSamuel Berhane\r\n\r\n<br \/><br \/>\r\n\r\n<strong>Addis Ababa University, College of Health Sciences, Department of Internal Medicine and Cardiology, Addis Ababa, Ethiopia\r\n<\/strong>    <br \/>                                                                            \r\nDejuma Yadeta\r\n\r\n<br \/><br \/>\r\n\r\n<strong>Mekelle University, College of Health Sciences, Department of Pediatrics and Child Health, Mekelle, Ethiopia\r\n<\/strong>    <br \/>                                                                            \r\nMarta Yemane<br \/>\r\nAbadi Leul\r\n\r\n<br \/><br \/>\r\n\r\n<strong>Etiopia-Witten Development Aid Association, Bahnhofstrasse 57, D58452 Witten, Germany\r\n<\/strong>    <br \/>                                                                            \r\nGabriele Wehr<br \/>\r\nChristian Leuner\r\n\r\n<br \/><br \/>\r\n\r\n<strong>Jimma University, Institute of Health Sciences, Department of Internal Medicine, Jimma, Ethiopia\r\n<\/strong>    <br \/>                                                                            \r\nTadesse Dukessa\r\n\r\n<br \/><br \/>\r\n\r\n<strong>Jimma University, Institute of Health Sciences, Department of Pediatrics and Child Health, Jimma, Ethiopia\r\n<\/strong>    <br \/>                                                                            \r\nAbraham Haileamlak\r\n\r\n<br \/><br \/>\r\n                                                                                                                                                                                                                                        \r\n\r\n                [soshsc hide=\"logged\"]\r\n                <strong>You need to be <a style=\"color: #c80c44;\" href=\"https:\/\/cvja.co.za\/journal\/member-login\/\" target=\"_blank\" rel=\"noopener\">logged in to view and download<\/a> the full text PDF version. <a style=\"color: #c80c44;\" href=\"https:\/\/cvja.co.za\/journal\/register\/\" target=\"_blank\" rel=\"noopener\">Register for a free account?<\/a><\/strong> <br \/><br \/>[\/soshsc]\r\n                \r\n                \r\n                \r\n                <\/div>\r\n    \r\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Intramuscular (IM) Benzathine penicillin G administration (BPG) is essential to prevent the progression of acute rheumatic fever (RF) to rheumatic heart disease (RHD). Fatal adverse events during BPG administration have been reported. This study aimed to characterise the clinical features and outcomes of RHD patients who developed adverse events with BPG administration for RHD prophylaxis in Ethiopia.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[44,108],"tags":[],"class_list":["post-5255","post","type-post","status-publish","format-standard","hentry","category-cardiovascular-topics","category-volume-36-issue-4"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Clinical and echocardiographic characteristics of patients who developed adverse events following Benzathine penicillin G injection for secondary prophylaxis of rheumatic heart disease: a cross-sectional study from three university hospitals in Ethiopia - Cardiovascular Journal of Africa<\/title>\n<meta name=\"description\" content=\"Intramuscular (IM) Benzathine penicillin G administration (BPG) is essential to prevent the progression of acute rheumatic fever (RF) to rheumatic heart disease (RHD). Fatal adverse events during BPG administration have been reported. This study aimed to characterise the clinical features and outcomes of RHD patients who developed adverse events with BPG administration for RHD prophylaxis in Ethiopia.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical and echocardiographic characteristics of patients who developed adverse events following Benzathine penicillin G injection for secondary prophylaxis of rheumatic heart disease: a cross-sectional study from three university hospitals in Ethiopia - Cardiovascular Journal of Africa\" \/>\n<meta property=\"og:description\" content=\"Intramuscular (IM) Benzathine penicillin G administration (BPG) is essential to prevent the progression of acute rheumatic fever (RF) to rheumatic heart disease (RHD). Fatal adverse events during BPG administration have been reported. This study aimed to characterise the clinical features and outcomes of RHD patients who developed adverse events with BPG administration for RHD prophylaxis in Ethiopia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/\" \/>\n<meta property=\"og:site_name\" content=\"Cardiovascular Journal of Africa\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-27T09:15:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-05T14:02:55+00:00\" \/>\n<meta name=\"author\" content=\"Jaco Moolman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jaco Moolman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/\",\"url\":\"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/\",\"name\":\"Clinical and echocardiographic characteristics of patients who developed adverse events following Benzathine penicillin G injection for secondary prophylaxis of rheumatic heart disease: a cross-sectional study from three university hospitals in Ethiopia - Cardiovascular Journal of Africa\",\"isPartOf\":{\"@id\":\"https:\/\/cvja.co.za\/journal\/#website\"},\"datePublished\":\"2025-10-27T09:15:21+00:00\",\"dateModified\":\"2026-05-05T14:02:55+00:00\",\"author\":{\"@id\":\"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/6bf8a30a039e93fd8112db707affb920\"},\"description\":\"Intramuscular (IM) Benzathine penicillin G administration (BPG) is essential to prevent the progression of acute rheumatic fever (RF) to rheumatic heart disease (RHD). Fatal adverse events during BPG administration have been reported. This study aimed to characterise the clinical features and outcomes of RHD patients who developed adverse events with BPG administration for RHD prophylaxis in Ethiopia.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cvja.co.za\/journal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical and echocardiographic characteristics of patients who developed adverse events following Benzathine penicillin G injection for secondary prophylaxis of rheumatic heart disease: a cross-sectional study from three university hospitals in Ethiopia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvja.co.za\/journal\/#website\",\"url\":\"https:\/\/cvja.co.za\/journal\/\",\"name\":\"Cardiovascular Journal of Africa\",\"description\":\"The Cardiovascular Journal of Africa is a peer-reviewed medical journal publishing leading research in cardiovascular health across Africa since 1990\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvja.co.za\/journal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/6bf8a30a039e93fd8112db707affb920\",\"name\":\"Jaco Moolman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/454c6719ed785bfd40e036ca3c3ac3347c56b4a99902df8beb62d882b1e6967f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/454c6719ed785bfd40e036ca3c3ac3347c56b4a99902df8beb62d882b1e6967f?s=96&d=mm&r=g\",\"caption\":\"Jaco Moolman\"},\"url\":\"https:\/\/cvja.co.za\/journal\/author\/jacodesignconnection-co-za\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical and echocardiographic characteristics of patients who developed adverse events following Benzathine penicillin G injection for secondary prophylaxis of rheumatic heart disease: a cross-sectional study from three university hospitals in Ethiopia - Cardiovascular Journal of Africa","description":"Intramuscular (IM) Benzathine penicillin G administration (BPG) is essential to prevent the progression of acute rheumatic fever (RF) to rheumatic heart disease (RHD). Fatal adverse events during BPG administration have been reported. This study aimed to characterise the clinical features and outcomes of RHD patients who developed adverse events with BPG administration for RHD prophylaxis in Ethiopia.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/","og_locale":"en_US","og_type":"article","og_title":"Clinical and echocardiographic characteristics of patients who developed adverse events following Benzathine penicillin G injection for secondary prophylaxis of rheumatic heart disease: a cross-sectional study from three university hospitals in Ethiopia - Cardiovascular Journal of Africa","og_description":"Intramuscular (IM) Benzathine penicillin G administration (BPG) is essential to prevent the progression of acute rheumatic fever (RF) to rheumatic heart disease (RHD). Fatal adverse events during BPG administration have been reported. This study aimed to characterise the clinical features and outcomes of RHD patients who developed adverse events with BPG administration for RHD prophylaxis in Ethiopia.","og_url":"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/","og_site_name":"Cardiovascular Journal of Africa","article_published_time":"2025-10-27T09:15:21+00:00","article_modified_time":"2026-05-05T14:02:55+00:00","author":"Jaco Moolman","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jaco Moolman","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/","url":"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/","name":"Clinical and echocardiographic characteristics of patients who developed adverse events following Benzathine penicillin G injection for secondary prophylaxis of rheumatic heart disease: a cross-sectional study from three university hospitals in Ethiopia - Cardiovascular Journal of Africa","isPartOf":{"@id":"https:\/\/cvja.co.za\/journal\/#website"},"datePublished":"2025-10-27T09:15:21+00:00","dateModified":"2026-05-05T14:02:55+00:00","author":{"@id":"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/6bf8a30a039e93fd8112db707affb920"},"description":"Intramuscular (IM) Benzathine penicillin G administration (BPG) is essential to prevent the progression of acute rheumatic fever (RF) to rheumatic heart disease (RHD). Fatal adverse events during BPG administration have been reported. This study aimed to characterise the clinical features and outcomes of RHD patients who developed adverse events with BPG administration for RHD prophylaxis in Ethiopia.","breadcrumb":{"@id":"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvja.co.za\/journal\/cvja-2025-080\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cvja.co.za\/journal\/cvja-2025-080\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cvja.co.za\/journal\/"},{"@type":"ListItem","position":2,"name":"Clinical and echocardiographic characteristics of patients who developed adverse events following Benzathine penicillin G injection for secondary prophylaxis of rheumatic heart disease: a cross-sectional study from three university hospitals in Ethiopia"}]},{"@type":"WebSite","@id":"https:\/\/cvja.co.za\/journal\/#website","url":"https:\/\/cvja.co.za\/journal\/","name":"Cardiovascular Journal of Africa","description":"The Cardiovascular Journal of Africa is a peer-reviewed medical journal publishing leading research in cardiovascular health across Africa since 1990","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvja.co.za\/journal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/6bf8a30a039e93fd8112db707affb920","name":"Jaco Moolman","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/454c6719ed785bfd40e036ca3c3ac3347c56b4a99902df8beb62d882b1e6967f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/454c6719ed785bfd40e036ca3c3ac3347c56b4a99902df8beb62d882b1e6967f?s=96&d=mm&r=g","caption":"Jaco Moolman"},"url":"https:\/\/cvja.co.za\/journal\/author\/jacodesignconnection-co-za\/"}]}},"_links":{"self":[{"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/posts\/5255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/comments?post=5255"}],"version-history":[{"count":1,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/posts\/5255\/revisions"}],"predecessor-version":[{"id":5549,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/posts\/5255\/revisions\/5549"}],"wp:attachment":[{"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/media?parent=5255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/categories?post=5255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/tags?post=5255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}